Filing Flows › GoodRx Holdings (GDRX) › Q1 2025
GoodRx Holdings (GDRX) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 7, 2025
GoodRx Holdings (GDRX) reported revenue of $203M for the first quarter 2025 (Q1 2025), +3% from a year earlier and +2% from the quarter before. Operating margin was 11.5%, net earnings $11.1M (5.4% of revenue).
GoodRx Holdings, Q1 2025: revenue $203M (+3% year over year), operating margin 11.5%, net earnings $11.1M, operating cash flow $9.4M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $203M | +2% | +3% |
| Operating profit | $23.4M | +29% | +217% |
| Net earnings | $11.1M | +64% | — |
| Operating cash flow | $9.4M | -79% | -78% |
| Free cash flow | $9.3M | -79% | -78% |
What changed
Revenue was $203.0M in Q1 2025, up 3% year over year and up 2% from the previous quarter. Prescription transactions revenue was the largest line at 73% of revenue. Pharma manufacturer solutions revenue added $4.1M year over year (up 17%), 81% of the total change. Other revenue declined 18%.
Operating profit was $23.4M, a 11.5% margin (up 7.8 points year over year). Of the extra revenue versus a year earlier, 314% reached operating profit, above the 4% margin then. Total costs fell 6% while revenue rose 3%. The fastest-growing cost line was Other operating costs (+31%). Net earnings were $11.1M. The effective tax rate was 33.7%.
Operating cash flow was $9.4M (down 78% year over year), 85% of net earnings. Non-cash charges added back $20.9M of depreciation and amortization and $19.2M of share-based compensation. Working capital and other items used $41.7M. Capital expenditures of $142K left free cash flow of $9.3M.
Questions
What was GoodRx Holdings' revenue in the first quarter 2025?
GoodRx Holdings (GDRX) reported revenue of $203M for the first quarter 2025 (Q1 2025), +3% from a year earlier and +2% from the quarter before.
Was GoodRx Holdings profitable in the first quarter 2025?
Operating profit was $23.4M (11.5% of revenue) and net earnings $11.1M.
Source: GoodRx Holdings 10-Q on SEC EDGAR.